VOTE FOR THE WEEKLY DOSE PODCAST!
CHECK OUT OUR SPONSOR: RO.CO/OTP
Semaglutide in Parkinsons and Opiod Abuse
https://www.wired.com/story/the-benefits-of-ozempic-are-multiplying/?
How Roche Passed on Orforglipron
https://www.swissinfo.ch/eng/multinational-companies/how-roche-passed-on-a-potential-14bn-a-year-weight-loss-pill/86877239?fbclid=IwZXh0bgNhZW0CMTEAAR1doDlsWIFXuUJYA9Kz75D9VvzZycgqm2kVbVPuWWFgOP0tvOVNvIWluVY_aem_GDMhnl8sQEVePWYy0XdheQ
Roche's Obesity Pipeline
https://www.onthepen.com/post/more-threats-to-lilly-s-tirzepatide-printing-press
Novo Announced Additional API Site
https://www.fiercepharma.com/pharma/novo-create-50-jobs-new-220m-raw-ingredients-plant-will-support-ozempic-and-wegovy
Patients Splitting Pens
https://www.theatlantic.com/health/archive/2024/08/ozempic-hackers/679464/
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors!
OTPLinks.com
Decoding GLP-1 Book
Decoding GLP-1: A Guide for Friends and Family of Those On The Pen
Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
Venmo: OnThePen
Ca$h App: ManOnMounjaro
BECOME A MEMBER:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
👉 My Amazon Affiliate Store:
https://www.amazon.com/shop/manonthemounjaroonthepen
WATCH MORE!
📺 We're Live M/W/F at 11 central: onthepen.tv
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.
